Jonathan Allan
Known title: GENERAL COUNSEL & CORP SECCIK: 0001966716
Associated companies
Transaction History
| STOK | ▼ Sell | Open Market | 627 | $17K | 10/2/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 2,716 | $87K | 8/18/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 145 | $5K | 8/18/2026 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 8/14/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 1,457 | $44K | 6/16/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 8,692 | $292K | 3/20/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 601 | $21K | 3/20/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 4,222 | $132K | 3/18/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 334 | $11K | 3/18/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 72 | $2K | 3/18/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 2,476 | $81K | 3/17/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 1,791 | $60K | 3/17/2026 | View on chart |
| STOK | ▲ Buy | Option Exercise | 7,475 | $0 | 3/15/2026 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 3/15/2026 | View on chart |
| STOK | ▲ Buy | Option Exercise | 12,000 | $0 | 3/15/2026 | View on chart |
| STOK | ▼ Sell | Open Market | 1,300 | $41K | 12/8/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 2,678 | $87K | 12/8/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,004 | $31K | 12/5/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 5,437 | $169K | 12/5/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 2,344 | $74K | 12/5/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 194 | $6K | 12/4/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 824 | $25K | 12/4/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 898 | $27K | 12/3/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,394 | $43K | 12/3/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 12/3/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 868 | $26K | 12/2/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,416 | $42K | 12/2/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 12,357 | $0 | 12/1/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 10,000 | $92K | 10/3/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 10,000 | $251K | 10/3/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 6,345 | $127K | 9/3/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 14,922 | $300K | 9/2/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 9,150 | $65K | 9/2/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 850 | $17K | 8/29/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 850 | $6K | 8/29/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,683 | $31K | 8/18/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 8/14/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 13,712 | $206K | 8/13/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,945 | $16K | 3/19/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 2,266 | $20K | 3/18/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 7,475 | $0 | 3/15/2025 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 3/15/2025 | View on chart |
| STOK | ▼ Sell | Open Market | 1,552 | $20K | 12/9/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 12,114 | $166K | 12/9/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 9,696 | $124K | 12/6/2024 | View on chart |
| STOK | ▲ Buy | Option Exercise | 6,000 | $0 | 12/3/2024 | View on chart |
| STOK | ▲ Buy | Option Exercise | 33,927 | $0 | 12/1/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 8,599 | $129K | 5/20/2024 | View on chart |
| STOK | ▲ Buy | Option Exercise | 8,599 | $61K | 5/20/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 5,026 | $66K | 3/28/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 100 | $1K | 3/28/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 2,349 | $14K | 3/19/2024 | View on chart |
| STOK | ▲ Buy | Option Exercise | 7,475 | $0 | 3/15/2024 | View on chart |
| STOK | ▼ Sell | Open Market | 1,948 | $26K | 6/21/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Stoke Therapeutics presents STK-002 data at AAO 2026 meeting
Stoke Therapeutics presented new data on its investigational drug STK-002 at the American Academy of Ophthalmology 2026 annual meeting. The data suggest the therapy may have disease-modifying potential for autosomal dominant optic atrophy. In a separate update, the company noted FDA alignment on endpoint criteria for its Zorevunersen program, which could affect future trial design.
Stoke Therapeutics presents STK-002 data at AAO 2026 meeting. Stoke Therapeutics presented new data on its investigational drug STK-002 at the American Academy of Ophthalmology 2026 annual meeting. The data suggest the therapy may have disease-modifying potential for autosomal dominant optic atrophy. In a separate update, the company noted FDA alignment on endpoint criteria for its Zorevunersen program, which could affect future trial design.